Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adapting Serosurveys for the SARS-CoV-2 Vaccine Era
Nathan Duarte, Mercedes Yanes‐Lane, Rahul K. Arora, et al.
Open Forum Infectious Diseases (2021) Vol. 9, Iss. 2
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies
Isabel Bergeri, Mairead Whelan, Harriet Ware, et al.
PLoS Medicine (2022) Vol. 19, Iss. 11, pp. e1004107-e1004107
Open Access | Times Cited: 216
SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021
Hannah C. Lewis, Harriet Ware, Mairead Whelan, et al.
BMJ Global Health (2022) Vol. 7, Iss. 8, pp. e008793-e008793
Open Access | Times Cited: 126
A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccination
Karen Colwill, Yannick Galipeau, Matthew Stuible, et al.
Clinical & Translational Immunology (2022) Vol. 11, Iss. 3
Open Access | Times Cited: 110
Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial
Youyi Fong, Adrian B. McDermott, David Benkeser, et al.
Nature Microbiology (2022) Vol. 7, Iss. 12, pp. 1996-2010
Open Access | Times Cited: 74
Contribution of infection and vaccination to population-level seroprevalence through two COVID waves in Tamil Nadu, India
T. S. Selvavinayagam, Anavarathan Somasundaram, Jerard Maria Selvam, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Global SARS-CoV-2 seroprevalence: a systematic review and meta-analysis of standardized population-based studies from Jan 2020-May 2022
Isabel Bergeri, Mairead Whelan, Harriet Ware, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 41
Omicron BA.1/1.1 SARS-CoV-2 Infection among Vaccinated Canadian Adults
Patrick Brown, Sze Hang Fu, Aiyush Bansal, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 24, pp. 2337-2339
Open Access | Times Cited: 26
Seroprevalence of Natural and Acquired Immunity against the SARS-CoV-2 Virus in a Population Cohort from Two Chilean Cities, 2020–2022
Loreto Núñez, Muriel Ramírez-Santana, Paola Rubilar, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 201-201
Open Access | Times Cited: 11
SARS-CoV-2 seropositivity amongst healthcare workers in South Africa during the Omicron wave: natural infection versus vaccination
Daniel Hoffmann, Pieter Meyer, Catherine Worsley, et al.
Journal of Clinical Pathology (2025), pp. jcp-209722
Closed Access
Implementing SARS-CoV-2 routine surveillance in antenatal care in Zambia, 2021–2022: best practices and lessons learned
Tannia Tembo, Elizabeth Heilmann, Bupe Kabamba, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Comparative Performance of Serum and Plasma Samples in SARS-CoV-2 Serology and Neutralization Assays
Hiba A. Chentoufi, Yannick Galipeau, Corey Arnold, et al.
Journal of Virological Methods (2025), pp. 115186-115186
Open Access
Comparative performance data for multiplex SARS-CoV-2 serological assays from a large panel of dried blood spot specimens
François Cholette, Rissa Fabia, Angela Harris, et al.
Heliyon (2022) Vol. 8, Iss. 9, pp. e10270-e10270
Open Access | Times Cited: 15
SARS-CoV-2 Antibody Prevalence among Industrial Livestock Operation Workers and Nearby Community Residents, North Carolina, 2021 to 2022
Carolyn Gigot, Nora Pisanic, Kate Kruczynski, et al.
mSphere (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 9
Occupation and SARS-CoV-2 seroprevalence studies: a systematic review
Emily Boucher, Christian Cao, Sean D’Mello, et al.
BMJ Open (2023) Vol. 13, Iss. 2, pp. e063771-e063771
Open Access | Times Cited: 8
Dynamics of SARS-CoV-2 seroassay sensitivity: a systematic review and modelling study
Nana Owusu‐Boaitey, Timothy Russell, Gideon Meyerowitz‐Katz, et al.
Eurosurveillance (2023) Vol. 28, Iss. 21
Open Access | Times Cited: 8
Serological surveillance of healthcare workers to evaluate natural infection- and vaccine-derived immunity to SARS-CoV-2 during an outbreak in Dili, Timor-Leste
Paul Arkell, Celia Gusmão, Sarah Sheridan, et al.
International Journal of Infectious Diseases (2022) Vol. 119, pp. 80-86
Open Access | Times Cited: 12
Trends in SARS-CoV-2 seroprevalence among pregnant women attending first antenatal care visits in Zambia: A repeated cross-sectional survey, 2021–2022
Elizabeth Heilmann, Tannia Tembo, Sombo Fwoloshi, et al.
PLOS Global Public Health (2024) Vol. 4, Iss. 4, pp. e0003073-e0003073
Open Access | Times Cited: 2
SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron
Sheila F. O’Brien, Niamh Caffrey, Qilong Yi, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2336-2336
Open Access | Times Cited: 11
A Mixture Model for Estimating SARS-CoV-2 Seroprevalence in Chennai, India
Matt D. T. Hitchings, Eshan U. Patel, Rifa Khan, et al.
American Journal of Epidemiology (2023) Vol. 192, Iss. 9, pp. 1552-1561
Open Access | Times Cited: 6
Ku-gaa-gii pimitizi-win, the COVID-19 cohort study of people experiencing homelessness in Toronto, Canada: a study protocol
Lucie Richard, Rosane Nisenbaum, Michael Liu, et al.
BMJ Open (2022) Vol. 12, Iss. 8, pp. e063234-e063234
Open Access | Times Cited: 10
A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination
Karen Colwill, Yannick Galipeau, Matthew Stuible, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 10
Realistic Estimation of COVID-19 Infection by Seroprevalence Surveillance of SARS-CoV-2 Antibodies: An Experience From Korea Metropolitan Area From January to May 2022
In Hwa Jeong, Jong‐Hun Kim, Min‐Jung Kwon, et al.
Journal of Korean Medical Science (2024) Vol. 39, Iss. 5
Open Access | Times Cited: 1
SARS-CoV-2 Seroprevalence and Vaccine Uptake among Pregnant Women at First Antenatal Care Visits in Malawi
Lyson Tenthani, Victoria Seffren, Alinune N. Kabaghe, et al.
American Journal of Tropical Medicine and Hygiene (2024) Vol. 110, Iss. 5, pp. 989-993
Open Access | Times Cited: 1
A seroprevalence study of SARS-CoV-2 and seasonal coronaviruses after the first SARS-CoV-2 circulation in New Caledonia, Pacific region
Karl Huet, Michael White, Anne-Fleur Griffon, et al.
IJID Regions (2024) Vol. 11, pp. 100373-100373
Open Access | Times Cited: 1
Hybrid immunity from severe acute respiratory syndrome coronavirus 2 infection and vaccination in Canadian adults: A cohort study
Patrick Brown, Sze Hang Fu, Leslie Newcombe, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top